Go Pro

Stryker (SYK) Stock Price, News & Analysis

Stryker logo
$326.41 -21.63 (-6.22%)
Closing price 07/31/2026 03:59 PM Eastern
Extended Trading
$325.84 -0.57 (-0.17%)
As of 07/31/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Stryker Stock (NYSE:SYK)

Advanced

Key Stats

Today's Range
$317.62
$334.46
50-Day Range
$293.36
$352.35
52-Week Range
$281.00
$401.99
Volume
4.54 million shs
Average Volume
2.25 million shs
Market Capitalization
$125.13 billion
P/E Ratio
33.82
Dividend Yield
1.08%
Price Target
$387.88
Consensus Rating
Moderate Buy

Company Overview

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment. Stryker also develops and supports robotic-assisted surgical systems and associated software aimed at improving procedural precision and outcomes.

Founded in 1941 by Dr. Homer Stryker, the company has grown through ongoing product development and strategic acquisitions to expand its technology portfolio and geographic reach. Stryker’s offerings include implants, capital equipment, instruments, disposables and digital solutions, together with training, service and clinical support for healthcare providers. The company serves a global customer base of hospitals, outpatient centers, clinicians and emergency responders and emphasizes research and development, clinical collaborations and post-market support to drive innovation and adoption.

Headquartered in Kalamazoo, Michigan, Stryker operates manufacturing, research and distribution facilities around the world and sells its products in numerous international markets across the Americas, Europe, Asia Pacific and other regions. The company is managed by an executive leadership team and overseen by a board of directors; its operations place ongoing emphasis on regulatory compliance, quality systems, clinical evidence generation and partnerships with healthcare professionals to advance patient care.

AI Generated. May Contain Errors.

Stryker Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
98th Percentile Overall Score

SYK MarketRank™: 

Stryker scored higher than 98% of companies evaluated by MarketBeat, and ranked 3rd out of 894 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Stryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 1 strong buy rating, 17 buy ratings, 5 hold ratings, and no sell ratings.

  • Upside Potential

    Stryker has a consensus price target of $387.88, representing about 18.8% upside from its current price of $326.41.

  • Amount of Analyst Coverage

    Stryker has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Stryker's stock forecast and price target.
  • Earnings Growth

    Earnings for Stryker are expected to grow by 10.53% in the coming year, from $15.01 to $16.59 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Stryker is 33.82, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 46.01.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Stryker is 33.82, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 282.25.

  • Price to Earnings Growth Ratio

    Stryker has a PEG Ratio of 2.09. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Stryker has a P/B Ratio of 5.57. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.92% of the float of Stryker has been sold short.
  • Short Interest Ratio / Days to Cover

    Stryker has a short interest ratio ("days to cover") of 2.68, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Stryker has recently increased by 1.53%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Stryker pays a meaningful dividend of 1.08%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Stryker has been increasing its dividend for 32 years.

  • Dividend Coverage

    The dividend payout ratio of Stryker is 40.74%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Stryker will have a dividend payout ratio of 21.22% next year. This indicates that Stryker will be able to sustain or increase its dividend.

  • Read more about Stryker's dividend.
  • News Sentiment

    Stryker has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 57 news articles for Stryker this week, compared to 9 articles on an average week.
  • Search Interest

    18 people have searched for SYK on MarketBeat in the last 30 days. This is an increase of 125% compared to the previous 30 days.
  • MarketBeat Follows

    21 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $100,659,489.00 in company stock.

  • Percentage Held by Insiders

    4.60% of the stock of Stryker is held by insiders.

  • Percentage Held by Institutions

    77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Stryker's insider trading history.
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SYK Stock News Headlines

Stryker (NYSE:SYK) Stock Price Down 7.5% on Analyst Downgrade
This AI fund posted a 34 percent annualized payout last month
One small fund tied to artificial intelligence stocks delivered $1,051 in a single month, not through selling shares or trading options, but simply by holding the fund and letting it pay out cash every Thursday. That works out to a 34% annualized distribution rate, even though the underlying AI stocks pay no dividends themselves. Tim Plaehn, Chief Income Strategist at Investors Alley, breaks down exactly how the fund generates these weekly payouts.tc pixel
Why Stryker (SYK) Stock Is Falling Today
Stryker (SYK) Q2 2026 Earnings
Stryker: Q2 Earnings Snapshot
See More Headlines

SYK Stock Analysis - Frequently Asked Questions

Stryker's stock was trading at $351.28 at the beginning of the year. Since then, SYK shares have decreased by 7.1% and is now trading at $326.4080.

Stryker Corporation (NYSE:SYK) posted its quarterly earnings data on Thursday, July, 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.49 by $0.20. The company's quarterly revenue was up 9.4% on a year-over-year basis.
Read the conference call transcript
.

The following companies are subsidiaries of Stryker: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and others.

Stryker's top institutional shareholders include Handelsbanken Fonder AB (0.07%), Confluence Investment Management LLC (0.06%), Chesley Taft & Associates LLC (0.04%) and E. Ohman J or Asset Management AB (0.03%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Preston Wendell Wells, Srikant M Datar, Glenn S Boehnlein and William E Berry Jr.
View institutional ownership trends
.

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Broadcom (AVGO), ServiceNow (NOW), BlackRock (BLK), NVIDIA (NVDA), Meta Platforms (META), UnitedHealth Group (UNH) and Advanced Micro Devices (AMD).

Company Calendar

Record date for 7/31 Dividend
6/30/2026
Ex-Dividend for 7/31 Dividend
6/30/2026
Last Earnings
7/30/2026
Dividend Payable
7/31/2026
Today
8/02/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NYSE:SYK
CIK
310764
Employees
56,000
Year Founded
1941

Price Target and Rating

High Price Target
$465.00
Low Price Target
$315.00
Potential Upside/Downside
+18.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.83
Research Coverage
23 Analysts

Profitability

EPS (Trailing Twelve Months)
$8.64
Trailing P/E Ratio
33.82
Forward P/E Ratio
21.75
P/E Growth
2.09
Net Income
$3.25 billion
Net Margins
14.43%
Pretax Margin
18.20%
Return on Equity
24.06%
Return on Assets
11.45%

Debt

Debt-to-Equity Ratio
0.62
Current Ratio
2.11
Quick Ratio
1.25

Sales & Book Value

Annual Sales
$25.12 billion
Price / Sales
4.98
Cash Flow
$16.93 per share
Price / Cash Flow
19.28
Book Value
$58.63 per share
Price / Book
5.57

Miscellaneous

Outstanding Shares
383,360,000
Free Float
365,726,000
Market Cap
$125.13 billion
Optionable
Optionable
Beta
0.77

Social Links

The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:SYK) was last updated on 8/2/2026 by MarketBeat.com Staff.
From Our Partners